NIFTY23,867.851.26%
SENSEX76,546.851.44%
BANKNIFTY55,905.350.71%
NIFTY IT28,572.255.15%
PHARMA22,671.901.37%
AUTO25,618.850.81%
FMCG50,636.200.99%
METAL12,708.400.61%
REALTY777.201.45%
ENERGY39,666.550.83%
NIFTY23,867.851.26%
SENSEX76,546.851.44%
BANKNIFTY55,905.350.71%
NIFTY IT28,572.255.15%
PHARMA22,671.901.37%
AUTO25,618.850.81%
FMCG50,636.200.99%
METAL12,708.400.61%
REALTY777.201.45%
ENERGY39,666.550.83%

Infosys' Revenue Growth Below Estimates, FY27E Growth Guidance Reflects Incremental Risks

Infosys' recent revenue growth performance has fallen short of expectations, with a quarter-over-quarter (QoQ) compound annual growth rate (CAGR) of -1.2%, contrary to Prabhudas Lilladher's estimates of -0.6% QoQ CAGR. This underperformance is attributed to seasonal fluctuations and slower deal ramp-ups. Additionally, geo-political conflicts and the impact of artificial intelligence (AI) deflation pose incremental risks to the company's growth prospects in FY27E.

Despite these challenges, Infosys has reported encouraging large deal wins, with a total of 96 deals secured, including three mega deals. Notably, the net-new large deal value (NN large deal TCV) stood at USD 8.2 billion, representing a 24% year-over-year (YoY) increase. However, the guidance for organic revenue growth (1.5%-3.5% CAGR) takes into account the planned ramp-down with a European client and the right-shoring impact, which would otherwise have contributed to additional growth in FY27E.

The management has expressed confidence in the BFSI (Banking, Financial Services, and Insurance) and ER&U (Energy, Resources, and Utilities) verticals, which are expected to contribute substantially to the company's topline growth, driven by notable large wins in these sectors (80% of NN ER&U). On the margin front, Prabhudas Lilladher is maintaining a tight band due to the company's increased investments in sales and marketing (S&M) and hiring/re-skilling AI talents, which are partly offset by the project Maximus.

Read also: Thyrocare Expects 84.9% Year-on-Year Increase in Q4 Net Profit

Outlook and Recommendations

Prabhudas Lilladher is projecting compound annual growth rates (CAGR) of 3.3% in FY27E, translating to overall CAGR growth of 5.0% and 6.3% in FY27E and FY28E, respectively. The research house is keeping its margin estimates largely unchanged. A price-to-earnings (PE) ratio of 18x (20x earlier) is assigned to FY28 earnings per share (EPS), with a target price of Rs. 1,570. The recommendation for Infosys is retained as BUY.

FY27E/FY28ECC Organic Revenue GrowthCC Growth YoYPE RatioTarget Price
FY27E3.3%5.0%--
FY28E-6.3%18xRs. 1,570

Investor Takeaway

Investors should be cautious of Infosys' revenue growth performance and potential risks to FY27E growth.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
help@iposcanner.ai.

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.